Role of CytoSorb hemoadsorption therapy in endocarditis patients
- Cardiac Surgery
EACTS - CytoSorbents Symposium 2
Role of CytoSorb hemoadsorption therapy in endocarditis patients
Chair: Carlos Mestres, Zurich/Switzerland
- Intraoperative use – First results from the REMOVE trial
Torsten Doenst, Jena/Germany - Intraoperative and postoperative use – Which patients benefit most?
Daniel Wendt, Essen/Germany - Can hemoadsorption reduce the amount of postoperative vasoactive drugs?
Anna Holmén, Gothenburg/Sweden - We need an individualized approach – Results of a large retrospective study
Jurij Kalisnik, Nuernberg/Germany
Share
|
Role of CytoSorb hemoadsorption therapy in endocarditis patients
Share
|
EACTS - CytoSorbents Symposium 2
Role of CytoSorb hemoadsorption therapy in endocarditis patients
Chair: Carlos Mestres, Zurich/Switzerland
- Intraoperative use – First results from the REMOVE trial
Torsten Doenst, Jena/Germany - Intraoperative and postoperative use – Which patients benefit most?
Daniel Wendt, Essen/Germany - Can hemoadsorption reduce the amount of postoperative vasoactive drugs?
Anna Holmén, Gothenburg/Sweden - We need an individualized approach – Results of a large retrospective study
Jurij Kalisnik, Nuernberg/Germany
More Videos
Role of CytoSorb hemoadsorption therapy in endocarditis patients - Symposium 2
Hemoadsorption with CytoSorb in various cardiac surgery indications